These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32848127)

  • 1. CFTR trafficking mutations disrupt cotranslational protein folding by targeting biosynthetic intermediates.
    Shishido H; Yoon JS; Yang Z; Skach WR
    Nat Commun; 2020 Aug; 11(1):4258. PubMed ID: 32848127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of NBD1 thermal stability is necessary and sufficient to correct ∆F508 CFTR folding and assembly.
    He L; Aleksandrov AA; An J; Cui L; Yang Z; Brouillette CG; Riordan JR
    J Mol Biol; 2015 Jan; 427(1):106-20. PubMed ID: 25083918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A small molecule high throughput screening platform to profile conformational properties of nascent, ribosome-bound proteins.
    Shishido H; Yoon JS; Skach WR
    Sci Rep; 2022 Feb; 12(1):2509. PubMed ID: 35169219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cystic fibrosis-causing mutation deltaF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis.
    Thibodeau PH; Richardson JM; Wang W; Millen L; Watson J; Mendoza JL; Du K; Fischman S; Senderowitz H; Lukacs GL; Kirk K; Thomas PJ
    J Biol Chem; 2010 Nov; 285(46):35825-35. PubMed ID: 20667826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the deltaF508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure.
    Lewis HA; Zhao X; Wang C; Sauder JM; Rooney I; Noland BW; Lorimer D; Kearins MC; Conners K; Condon B; Maloney PC; Guggino WB; Hunt JF; Emtage S
    J Biol Chem; 2005 Jan; 280(2):1346-53. PubMed ID: 15528182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of a nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator yields insight into disease-causing mutations.
    Vernon RM; Chong PA; Lin H; Yang Z; Zhou Q; Aleksandrov AA; Dawson JE; Riordan JR; Brouillette CG; Thibodeau PH; Forman-Kay JD
    J Biol Chem; 2017 Aug; 292(34):14147-14164. PubMed ID: 28655774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory insertion removal restores maturation, stability and function of DeltaF508 CFTR.
    Aleksandrov AA; Kota P; Aleksandrov LA; He L; Jensen T; Cui L; Gentzsch M; Dokholyan NV; Riordan JR
    J Mol Biol; 2010 Aug; 401(2):194-210. PubMed ID: 20561529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-driven vectorial folding of ribosome-bound human CFTR NBD1.
    Khushoo A; Yang Z; Johnson AE; Skach WR
    Mol Cell; 2011 Mar; 41(6):682-92. PubMed ID: 21419343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The primary folding defect and rescue of ΔF508 CFTR emerge during translation of the mutant domain.
    Hoelen H; Kleizen B; Schmidt A; Richardson J; Charitou P; Thomas PJ; Braakman I
    PLoS One; 2010 Nov; 5(11):e15458. PubMed ID: 21152102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substitution of Yor1p NBD1 residues improves the thermal stability of Human Cystic Fibrosis Transmembrane Conductance Regulator.
    Xavier BM; Hildebrandt E; Jiang F; Ding H; Kappes JC; Urbatsch IL
    Protein Eng Des Sel; 2017 Oct; 30(10):729-741. PubMed ID: 29053845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cystic fibrosis V232D mutation inhibits CFTR maturation by disrupting a hydrophobic pocket rather than formation of aberrant interhelical hydrogen bonds.
    Loo TW; Clarke DM
    Biochem Pharmacol; 2014 Mar; 88(1):46-57. PubMed ID: 24412276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated biophysical studies implicate partial unfolding of NBD1 of CFTR in the molecular pathogenesis of F508del cystic fibrosis.
    Wang C; Protasevich I; Yang Z; Seehausen D; Skalak T; Zhao X; Atwell S; Spencer Emtage J; Wetmore DR; Brouillette CG; Hunt JF
    Protein Sci; 2010 Oct; 19(10):1932-47. PubMed ID: 20687163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR.
    Du K; Sharma M; Lukacs GL
    Nat Struct Mol Biol; 2005 Jan; 12(1):17-25. PubMed ID: 15619635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis transmembrane conductance regulator (CFTR) potentiators protect G551D but not ΔF508 CFTR from thermal instability.
    Liu X; Dawson DC
    Biochemistry; 2014 Sep; 53(35):5613-8. PubMed ID: 25148434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Scanning Fluorimetry and Hydrogen Deuterium Exchange Mass Spectrometry to Monitor the Conformational Dynamics of NBD1 in Cystic Fibrosis.
    Soya N; Roldan A; Lukacs GL
    Methods Mol Biol; 2019; 1873():53-67. PubMed ID: 30341603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diminished self-chaperoning activity of the DeltaF508 mutant of CFTR results in protein misfolding.
    Serohijos AW; Hegedus T; Riordan JR; Dokholyan NV
    PLoS Comput Biol; 2008 Feb; 4(2):e1000008. PubMed ID: 18463704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing conformational rescue induced by a chemical corrector of F508del-cystic fibrosis transmembrane conductance regulator (CFTR) mutant.
    Yu W; Kim Chiaw P; Bear CE
    J Biol Chem; 2011 Jul; 286(28):24714-25. PubMed ID: 21602569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conserved allosteric hot spots in the transmembrane domains of cystic fibrosis transmembrane conductance regulator (CFTR) channels and multidrug resistance protein (MRP) pumps.
    Wei S; Roessler BC; Chauvet S; Guo J; Hartman JL; Kirk KL
    J Biol Chem; 2014 Jul; 289(29):19942-57. PubMed ID: 24876383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubilizing mutations used to crystallize one CFTR domain attenuate the trafficking and channel defects caused by the major cystic fibrosis mutation.
    Pissarra LS; Farinha CM; Xu Z; Schmidt A; Thibodeau PH; Cai Z; Thomas PJ; Sheppard DN; Amaral MD
    Chem Biol; 2008 Jan; 15(1):62-9. PubMed ID: 18215773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Domain-interface dynamics of CFTR revealed by stabilizing nanobodies.
    Sigoillot M; Overtus M; Grodecka M; Scholl D; Garcia-Pino A; Laeremans T; He L; Pardon E; Hildebrandt E; Urbatsch I; Steyaert J; Riordan JR; Govaerts C
    Nat Commun; 2019 Jun; 10(1):2636. PubMed ID: 31201318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.